Impact of Obesity on Plasma Natriuretic Peptide Levels-Reference-Cited by-同舟云学术

Impact of Obesity on Plasma Natriuretic Peptide Levels

Published:2004-02-10 Issue:5 Volume:109 Page:594-600
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Wang Thomas J.¹,Larson Martin G.¹,Levy Daniel¹,Benjamin Emelia J.¹,Leip Eric P.¹,Wilson Peter W.F.¹,Vasan Ramachandran S.¹

Affiliation:

1. From the Framingham Heart Study, Framingham, Mass; Cardiology Division (T.J.W.), Massachusetts General Hospital, Harvard Medical School, Boston, Mass; National Heart, Lung & Blood Institute (D.L.), Bethesda, Md; and Sections of Cardiology (D.L., E.J.B., R.S.V.) and Preventive Medicine (D.L., E.J.B., P.W.F.W., R.S.V.), Boston Medical Center, Boston University School of Medicine, Boston, Mass.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference32 articles.

1. The Kidney, Hypertension, and Obesity

2. The Impact of Obesity on Left Ventricular Mass and Geometry

3. The Effect of Weight Loss on the Sensitivity of Blood Pressure to Sodium in Obese Adolescents

4. A dietary fibre supplement in the treatment of mild hypertension. A randomized, double-blind, placebo-controlled trial

5. Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients

Cited by 836 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brain natriuretic peptide and N-terminal pro b-type natriuretic peptide in kidney transplantation: More than just cardiac markers;Transplantation Reviews;2024-12

2. Blunted increase in plasma BNP during acute coronary syndrome attacks in obese patients;IJC Heart & Vasculature;2024-10

3. Association of N‐terminal pro‐B natriuretic peptide with all‐cause mortality and cardiovascular mortality in obese and non‐obese populations and the development of a machine learning prediction model: National Health and Nutrition Examination Survey (NHANES) 1999–2004;Diabetes, Obesity and Metabolism;2024-09-06

4. Letter by Weir Regarding Article, “Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction and Obesity”;Circulation;2024-09-03

5. Role of dietary inflammatory index in the association of NT-proBNP with all-cause and cardiovascular mortality in NHANES 1999–2004;Scientific Reports;2024-08-28